GILEAD SCIENCES, INC. Quarterly Return On Equity in % from Q4 2010 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Gilead Sciences, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2010 to Q3 2024.
  • Gilead Sciences, Inc. Return On Equity for the quarter ending September 30, 2024 was 0.66 %, a 97.6% decline year-over-year.
  • Gilead Sciences, Inc. annual Return On Equity for 2023 was 26 %, a 16.8% increase from 2022.
  • Gilead Sciences, Inc. annual Return On Equity for 2022 was 22.3 %, a 27.3% decline from 2021.
  • Gilead Sciences, Inc. annual Return On Equity for 2021 was 30.7 %, a 4636% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 0.66 -26.8 -97.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 5.23 -20.8 -79.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 2.32 -24.5 -91.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 26 +3.75 +16.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 27.5 +11.3 +69.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 26 +6 +30% Apr 1, 2023 Jun 30, 2023
Q1 2023 26.8 +4.79 +21.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 22.3 -8.37 -27.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 16.2 -21.5 -57% Jul 1, 2022 Sep 30, 2022
Q2 2022 20 -7.75 -27.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 22 +20.3 +1229% Jan 1, 2022 Mar 31, 2022
Q4 2021 30.7 +30 +4636% Oct 1, 2021 Dec 31, 2021
Q3 2021 37.7 +31.4 +499% Jul 1, 2021 Sep 30, 2021
Q2 2021 27.8 +29 Apr 1, 2021 Jun 30, 2021
Q1 2021 1.65 -20.8 -92.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 0.65 -23.8 -97.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 6.31 -6.06 -49% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.23 -27.9 -105% Apr 1, 2020 Jun 30, 2020
Q1 2020 22.5 -4.2 -15.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 24.4 -0.68 Oct 1, 2019 Dec 31, 2019
Q3 2019 12.4 +4.98 +67.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 26.7 +16.6 +166% Apr 1, 2019 Jun 30, 2019
Q1 2019 26.7 +11.2 +72.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 25.1* +4.48 Oct 1, 2018 Dec 31, 2018
Q3 2018 7.39 -45 -85.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 10 -50.5 -83.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 15.5 -53.1 -77.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 20.6 -60.2 -74.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 52.4 -38.2 -42.2% Jul 1, 2017 Sep 30, 2017
Q2 2017 60.5 -36.8 -37.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 68.5 -33.9 -33.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 80.8 -20.8 -20.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 90.5 -8.97 -9.02% Jul 1, 2016 Sep 30, 2016
Q2 2016 97.3 +3.15 +3.35% Apr 1, 2016 Jun 30, 2016
Q1 2016 102 +13.2 +14.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 102 +20.7 +25.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 99.5 +32 +47.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 94.2 +37.9 +67.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 89.2 +51 +134% Jan 1, 2015 Mar 31, 2015
Q4 2014 80.9 +53.4 +194% Oct 1, 2014 Dec 31, 2014
Q3 2014 67.5 +38.8 +135% Jul 1, 2014 Sep 30, 2014
Q2 2014 56.3 +26.9 +91.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 38.2 +6.94 +22.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 27.5 -3.19 -10.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 28.7 -3.42 -10.6% Jul 1, 2013 Sep 30, 2013
Q2 2013 29.3 -2.37 -7.48% Apr 1, 2013 Jun 30, 2013
Q1 2013 31.2 -3.18 -9.24% Jan 1, 2013 Mar 31, 2013
Q4 2012 30.7 -8.58 -21.8% Oct 1, 2012 Dec 31, 2012
Q3 2012 32.1 -7.8 -19.5% Jul 1, 2012 Sep 30, 2012
Q2 2012 31.7 -13.1 -29.3% Apr 1, 2012 Jun 30, 2012
Q1 2012 34.4 -8.96 -20.7% Jan 1, 2012 Mar 31, 2012
Q4 2011 39.3 -4.98 -11.2% Oct 1, 2011 Dec 31, 2011
Q3 2011 39.9 Jul 1, 2011 Sep 30, 2011
Q2 2011 44.8 Apr 1, 2011 Jun 30, 2011
Q1 2011 43.4 Jan 1, 2011 Mar 31, 2011
Q4 2010 44.3 Oct 1, 2010 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.